Literature DB >> 1560189

Large parathyroid functioning carcinoma (1,200 g) presenting as a substernal goiter.

A Avramides1, K Papamargaritis, A Antoniadis, D Gakis, M Leontsini.   

Abstract

Parathyroid carcinoma is a rare tumor responsible for 0.5-5% of primary hyperparathyroidism. It is usually small (not more than 27 g) and the precise diagnosis of malignancy is made when local or distant metastases are found. We describe a case of a 37 yr old male presenting with a substernal goiter and no specific symptoms except hypertension. This mass had cysts and calcifications and it was in the anterior upper mediastinum. The patient had severe hypercalcemia (Ca greater than 14 mg/dl), high PTH levels and mild renal failure. Bone scanning showed signs of hyperparathyroidism. The patient was subjected to total thyroidectomy and removal of the mass en block. The tumor was circumscribed lobulated and mostly cystic. It weighed 1,200 g (380 g after evacuation of cysts) and measured 12 x 9 x 4.5 cm. Histologic examination showed a highly differentiated adenocarcinoma of parathyroid with metastasis in a regional lymph node. Almost 4 years later the patient is alive and well without hypercalcemia and without evidence of distant metastases.

Entities:  

Mesh:

Year:  1992        PMID: 1560189     DOI: 10.1007/BF03348653

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  13 in total

1.  Calcitonin treatment of hypercalcemia due to parathyroid carcinoma. Synergistic effect of prednisone on long-term treatment of hypercalcemia.

Authors:  W Y Au
Journal:  Arch Intern Med       Date:  1975-12

2.  Parathyroid carcinoma. A study of 70 cases.

Authors:  A Schantz; B Castleman
Journal:  Cancer       Date:  1973-03       Impact factor: 6.860

3.  Disodium clodronate effective in management of severe hypercalcaemia caused by parathyroid carcinoma.

Authors:  D Jüngst
Journal:  Lancet       Date:  1984-11-03       Impact factor: 79.321

Review 4.  Parathyroid carcinoma: a review of 62 patients.

Authors:  E Shane; J P Bilezikian
Journal:  Endocr Rev       Date:  1982       Impact factor: 19.871

5.  Nonsecretory parathyroid carcinoma of the mediastinum. Light microscopic, immunocytochemical, and ultrastructural features of a case, and review of the literature.

Authors:  M N Murphy; P G Glennon; M S Diocee; M R Wick; D J Cavers
Journal:  Cancer       Date:  1986-12-01       Impact factor: 6.860

6.  Parathyroid carcinoma of the oxyphil cell type. A report of two cases, light and electron microscopic study.

Authors:  T Obara; Y Fujimoto; K Yamaguchi; R Takanashi; I Kino; Y Sasaki
Journal:  Cancer       Date:  1985-04-01       Impact factor: 6.860

Review 7.  How to recognize and treat parathyroid carcinoma.

Authors:  Y Fujimoto; T Obara
Journal:  Surg Clin North Am       Date:  1987-04       Impact factor: 2.741

8.  Parathyroid carcinoma: a clinical study of seven cases of functioning and two cases of nonfunctioning parathyroid cancer.

Authors:  K A Aldinger; R C Hickey; M L Ibanez; N A Samaan
Journal:  Cancer       Date:  1982-01-15       Impact factor: 6.860

9.  Natural history of parathyroid carcinoma. Diagnosis, treatment, and results.

Authors:  C A Wang; R D Gaz
Journal:  Am J Surg       Date:  1985-04       Impact factor: 2.565

10.  Mitotic activity in benign parathyroid disease.

Authors:  D C Snover; K Foucar
Journal:  Am J Clin Pathol       Date:  1981-03       Impact factor: 2.493

View more
  2 in total

1.  Huge parathyroid carcinoma: clinical considerations and literature review.

Authors:  Maria Grazia Chiofalo; Francesco Scognamiglio; Simona Losito; Secondo Lastoria; Ugo Marone; Luciano Pezzullo
Journal:  World J Surg Oncol       Date:  2005-06-23       Impact factor: 2.754

Review 2.  Persistent Hypercalcemia Crisis and Recurrent Acute Pancreatitis Due to Multiple Ectopic Parathyroid Carcinomas: Case Report and Literature Review of Mediastinal Parathyroid Carcinoma.

Authors:  Ruizhi Jiajue; An Song; Ou Wang; Wei Li
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-10       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.